Royal Bank Of Canada Hoth Therapeutics, Inc. Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.36 - $9.25 $2,160 - $55,500	6,000 New	6,000 $2,000
Q3 2021 Nov 15, 2021	SELL	$1.15 - $1.62 $66 - $93	-58 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.31 - $2.14 $75 - $124	58 New	58 $0

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.11M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.